Ian Berry
Impact in
- Genetics top 10%
- Genomics and Rare Diseases
- Genetic and Kidney Cyst Diseases
- Connective tissue disorders research
-
- Cancer Genomics and Diagnostics
Papers in
- Genetics 11
- Genetic and Kidney Cyst Diseases 4
- Genetics and Neurodevelopmental Disorders 2
- Genomic variations and chromosomal abnormalities 2
- Connective tissue disorders research 2
-
- RNA Research and Splicing 2
- Co-authors
- Ruth Charlton (3 shared papers)Ian Carr (2 shared papers)David T. Bonthron (2 shared papers)Angus Dobbie (2 shared papers)Christopher M. Watson (1 shared paper)Agne Antanaviciute (1 shared paper)Sally M. Harrison (1 shared paper)Laura A. Crinnion (1 shared paper)
- Journals
- Human Mutation (2 papers)Familial Cancer (2 papers)Neuropediatrics (1 paper)European Journal of Medical Genetics (1 paper)Genetics in Medicine (1 paper)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
Ian Berry
23 papers receiving 382 citations
Peers
Comparison fields: 5 of 64
- Genetics 176
- Cancer Research 44
- Molecular Biology 197
- Pathology and Forensic Medicine 47
- Aging 5
Countries citing papers authored by Ian Berry
This map shows the geographic impact of Ian Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Berry more than expected).
Fields of papers citing papers by Ian Berry
This network shows the impact of papers produced by Ian Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Berry. The network helps show where Ian Berry may publish in the future.
Co-authors
The 25 scholars most cited alongside Ian Berry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 61 | |
| 2 | 2021 | 43 | |
| 3 | 2020 | 39 | |
| 4 | 2012 | 38 | |
| 5 | 2013 | 31 | |
| 6 | 2024 | 29 | |
| 7 | 2018 | 26 | |
| 8 | 2011 | 18 | |
| 9 | 2018 | 18 | |
| 10 | 2019 | 17 | |
| 11 | 2021 | 14 | |
| 12 | 2017 | 9 | |
| 13 | 2016 | 6 | |
| 14 | 2017 | 6 | |
| 15 | 2021 | 5 | |
| 16 | 2021 | 5 | |
| 17 | 2007 | 5 | |
| 18 | 2024 | 4 | |
| 19 | 2012 | 3 | |
| 20 | 2007 | 3 |
About Ian Berry
Ian Berry is a scholar working on Genetics, Molecular Biology, Pathology and Forensic Medicine, Cancer Research and Surgery, having authored 23 papers that have together received 385 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (4 papers), Genetic and Kidney Cyst Diseases (4 papers), Genetic factors in colorectal cancer (4 papers), Genetics and Neurodevelopmental Disorders (2 papers), Bone and Dental Protein Studies (2 papers), Genomic variations and chromosomal abnormalities (2 papers), RNA Research and Splicing (2 papers) and Connective tissue disorders research (2 papers). The work is most often cited by research in Genetics (176 citations), Cancer Research (44 citations), Molecular Biology (197 citations), Pathology and Forensic Medicine (47 citations) and Aging (5 citations). Ian Berry has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Ruth Charlton, Ian Carr, David T. Bonthron, Angus Dobbie, Christopher M. Watson, Agne Antanaviciute, Sally M. Harrison, Laura A. Crinnion, Colin A. Johnson and James Drummond. Their work appears in journals such as Human Mutation, Familial Cancer, Neuropediatrics, European Journal of Medical Genetics and Genetics in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.